Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain

Transfusion

Volumn 36, Issue 8, 1996, Pages 725-730

  Echevarria J M ^a   Leon P ^b   Domingo, C J ^c   Lopez J A ^c   Elola, C ^c   Madurga, M ^d   Salmeron F ^d   Yap, P L ^e   Daub, J ^f   Simmonds, P ^f  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b Institutode Salud Carlos III ^*  (Spain)

^c Ctro Nac Microbiol Virologia I   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e S E Scotland Blood Transfus Serv   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADOLESCENT; ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHILD; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LABORATORY DIAGNOSIS; MALE; REINFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SPAIN; VIRUS INFECTION;

EID: 10144256488     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36896374377.x     Document Type: Article

References (31)

1. Duhem C, Dicato MA, Ries F. Side-effects of intravenous immune globulins. Clin Exp Immunol 1994;97(Suppl 1):79-83.
2. Bjoro K, Froland SS, Yun Z, et al. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994;331:1607-11.
3. Dodd LG, McBride JH, Gitnick GL, et al. Prevalence of non-A,non-B hepatitis/hepatitis C virus antibody in human immunoglobulins. Am J Clin Pathol 1992;97:108-13.
4. Lefrère JJ, Mariotti M, Trepo C, et al. Testing for HCV-RNA in commercial intravenous immunoglobulins (letter). Lancet 1993;341:834-5.
5. Habibi B, Garretta M. Screening for hepatitis C virus antibody in plasma for fractionation (letter). Lancet 1990;335:855-6.
6. Minor P. Testing of blood for antibodies to hepatitis C virus - implications for plasma pools used in the preparation of blood products. Biologicals 1991;19:253-6.
7. Biswas RM, Nedjar S, Wilson LT, et al. The effect on the safety of intravenous immunoglobulin of testing plasma for antibody to hepatitis C. Transfusion 1994;34:100-4.
8. Pawlotsky JM, Bouvier M, Deforges L, et al. Chronic hepatitis C after high-dose intravenous immunoglobulin. Transfusion 1994;34:86-7.
9. Outbreak of hepatitis C associated with intravenous immunoglobulin administration - United States, October 1993-June 1994. MMWR Morb Mortal Wkly Rep 1994;43:505-9.
10. Schiff RI. Transmission of viral infections through intravenous immune globulin (editorial). N Engl J Med 1994;331:1649-50.
11. Yu MW, Mason BL, Guo ZP, et al. Hepatitis C transmission associated with intravenous immunoglobulins (letter). Lancet 1995;345:1173-4.
12. Hedman K, Seppälä I. Recent rubella virus infection indicated by a low avidity of specific IgG. J Clin Immunol 1988;8:214-21.
13. León P, López JA, Domingo CJ, et al. Serological studies and hepatitis C virus RNA in serum samples from blood donors with indeterminate results in second-generation recombinant immunoblot assay (letter). Vox Sang 1994;66:245-6.
14. Stuyver L, Rossau R, Wyseur A, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993;74:1093-102.
15. Simmonds P, McOmish F, Yap PL, et al. Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993;74:661-8.
16. Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 1990;170:1021-5.
17. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-9.
18. Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A 1990;87:9524-8.
19. Lau JY, Mizokami M, Kolberg JA, et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995;171:281-9.
20. Kudesia G, Price C, Clewley J. Passively transfused hepatitis C antibody (letter). Lancet 1992;340:1291.
21. Dammacco F, Sansonno D, Beardsley A, Gowans EJ. Failure to detect hepatitis C virus (HCV) genome by polymerase chain reaction in human anti-HCV-positive intravenous immunoglobulins. Clin Exp Immunol 1993;92:205-10.
22. León P, López JA, Elola C, et al. Characterization of hepatitis C virus infections among recipients of intravenous human immunoglobulin. In: Caragol I, Español T, Fontán G, Matamoros N, eds. Progress in Immune Deficiency, vol 5. Barcelona: Springer-Verlag Ibérica, 1995:122-3.
23. Hedman K, Lappalainen M, Söderlund M, Hedman L. Avidity of IgG in serodiagnosis of infectious diseases. Rev Med Microbiol 1993;4:123-9.
24. De Ory F, Casas I, Domingo CJ, Echevarría JM. Application of fluorimmunoassay to the identification of low avidity specific IgG against pathogenic human viruses and Toxoplasma gondii. Clin Diagn Virol 1995;3:323-32.
25. Ward KN, Dhaliwal W, Ashworth KL, et al. Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody. J Med Virol 1994;43:367-72.
26. Lok AS, Chien D, Choo QL, et al. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology 1993;18:497-502.
27. Jarvis LM, Watson HG, McOmish F, et al. Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs. J Infect Dis 1994;170:1018-22.
28. Chan SW, Simmonds P, McOmish F, et al. Serological responses to infection with three different types of hepatitis C virus (letter). Lancet 1991;338:1391.
29. Alonso C, Qu D, Lamelin JP, et al. Serological responses to different genotypes of hepatitis C virus in France. J Clin Microbiol 1994;32:211-2.
30. Ichimura H, Tamura I, Kurimura O, et al. Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease. J Med Virol 1994;43:212-5.
31. Nübling CM, Willkommen H, Löwer J. Hepatitis C transmission associated with intravenous immunoglobulins (letter). Lancet 1995;345:1174.